David Martínez Cuadrón-rekin lankidetzan egindako argitalpenak (9)

2021

  1. Impact of combinations of single-nucleotide polymorphisms of anthracycline transporter genes upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia

    Leukemia and Lymphoma, Vol. 62, Núm. 3, pp. 659-668

  2. Influence of polymorphisms in anthracyclines metabolism genes in the standard induction chemotherapy of acute myeloid leukemia

    Pharmacogenetics and Genomics, Vol. 31, Núm. 6, pp. 133-139

2018

  1. Impact of NADPH oxidase functional polymorphisms in acute myeloid leukemia induction chemotherapy

    Pharmacogenomics Journal, Vol. 18, Núm. 2, pp. 301-307

  2. Pharmacogenetics of metabolic genes of anthracyclines in acute myeloid leukemia

    Current Drug Metabolism, Vol. 19, Núm. 1, pp. 55-74

2017

  1. Impact of ABC single nucleotide polymorphisms upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia

    Leukemia and Lymphoma, Vol. 58, Núm. 5, pp. 1197-1206

  2. Impact of novel polymorphisms related to cytotoxicity of cytarabine in the induction treatment of acute myeloid leukemia

    Pharmacogenetics and Genomics, Vol. 27, Núm. 7, pp. 270-274

  3. Influence of cytarabine metabolic pathway polymorphisms in acute myeloid leukemia induction treatment

    Leukemia and Lymphoma, Vol. 58, Núm. 12, pp. 2880-2894

2016

  1. A systematic review and meta-analysis of the impact of WT1 polymorphism rs16754 in the effectiveness of standard chemotherapy in patients with acute myeloid leukemia

    Pharmacogenomics Journal, Vol. 16, Núm. 1, pp. 30-40

  2. Pharmacogenomics and the treatment of acute myeloid leukemia

    Pharmacogenomics, Vol. 17, Núm. 11, pp. 1245-1272